Inhaled asthma medicine might be an effective treatment for Alzheimer’s disease

Alzheimer’s disease (AD) is the most common form of dementia. A United Kingdom study gives hope for a novel treatment for AD.

Asthma Drug Off Label Use links to a study done a few months ago that gives unusual hope for those with early-onset AD. One of the causes of AD is tau protein tangles.

The drug, salbutamol, disrupts the early stage tau protein formation and inhibits it from reproducing.

The asthma drug remains in the body for several hours after inhaling. The brain absorbs it quickly. It has been through clinical tests for humans and is safe. Future development as an AD drug would be short and cost-effective.

Salbutamol is also sold under the names Ventolin, Airomir, Asmalal, Easyhaler, Pulvinal, Salamol, Easi-Breathe, and Salbulin. It is currently recommended for relief and prevention of bronchospasm caused by bronchial asthma, chronic bronchitis, and reversible obstructive airway disease.


Dementia, in all forms, creates more problems for the caregivers than those with the disease. I like the preliminary data regarding this asthma medication that already shows promise in treating AD.

Live Longer & Enjoy Life! – Red O’Laughin –



One Response

Leave a Reply

Your email address will not be published. Required fields are marked *